Over the years, a broad spectrum of applications of the radionuclide holmium-166 as a
medical isotope has been established. The isotope holmium-166 is attractive as it emits high …

Background With recent advances in novel approaches to cancer therapy and imaging, the
application of theranostic techniques in personalised medicine has emerged as a very …

Theranostics in nuclear medicine refers to personalized patient management that involves
targeted therapy and diagnostic imaging using a single or combination of radionuclide (s) …

Several radiolanthanides find their application in nuclear medicine because of their
favorable decay properties, the most important ones being 143 Pr, 149 Pm, 153 Sm, 165 Dy …

Therapeutic phosphonate-based radiopharmaceuticals radiolabeled with beta, alpha and
conversion electron emitting radioisotopes have been investigated for the targeted treatment …

Bone pain arising from secondary skeletal malignancy constitutes one of the most common
types of chronic pain among patients with cancer which can lead to rapid deterioration of the …

During past 3 decades, nuclear medicine has flourished as vibrant and independent
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …

Objective (s): In this study, 166 Ho-1, 2-propylene di-amino tetra (
methy1enephosphonicAcid)(166 Ho-PDTMP) complex was prepared as a bone palliation …

Skeletal metastases are common in patients suffering from various primary cancers.
Radiopharmaceuticals are an effective option for bone pain palliation. In this work, the …

Radiopharmaceutical therapy, which can detect and treat tumours simultaneously, was
introduced more than 80 years ago, and it has changed medical strategies with respect to …